Enzo Biochem Inc financial data

Symbol
ENZ on NYSE
Industry
Services-Medical Laboratories
Location
60 Executive Blvd, Farmingdale, NY
State of incorporation
NY
Fiscal year end
July 31
Latest financial report
10-Q - Q4 2024 - Mar 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 296 % +34.7%
Quick Ratio 30.5 % +7.55%
Debt-to-equity 46.8 % -27.7%
Return On Equity -38.9 % -172%
Return On Assets -26.5 % -181%
Operating Margin -34.1 % +51.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.4M shares +2.3%
Common Stock, Shares, Outstanding 52.4M shares +3.79%
Entity Public Float 57.5M USD +1.97%
Common Stock, Value, Issued 523K USD +3.77%
Weighted Average Number of Shares Outstanding, Basic 52.3K shares +3.58%
Weighted Average Number of Shares Outstanding, Diluted 52.3K shares +3.58%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 29.1M USD -11.3%
Cost of Revenue 16.6M USD -5.8%
Research and Development Expense 2.25M USD -35.8%
Operating Income (Loss) -9.93M USD +57.2%
Nonoperating Income (Expense) 354K USD -73.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.6M USD +67.4%
Net Income (Loss) Attributable to Parent -21.3M USD -165%
Earnings Per Share, Basic -0.42 USD/shares -163%
Earnings Per Share, Diluted -0.42 USD/shares -163%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40.3M USD -33.1%
Accounts Receivable, after Allowance for Credit Loss, Current 4.25M USD -17%
Inventory, Net 5.99M USD -23.2%
Assets, Current 52.2M USD -35.5%
Property, Plant and Equipment, Net 12.3M USD -4.16%
Operating Lease, Right-of-Use Asset 2.56M USD -19.6%
Goodwill 7.45M USD 0%
Other Assets, Noncurrent 481K USD -33.7%
Assets 67.5M USD -31.9%
Accrued Liabilities, Current 5.39M USD -28.4%
Liabilities, Current 17.2M USD -32.1%
Operating Lease, Liability, Noncurrent 2.1M USD -24.5%
Liabilities 20.9M USD -26.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.27M USD +11.1%
Retained Earnings (Accumulated Deficit) -299M USD -7.67%
Stockholders' Equity Attributable to Parent 46.6M USD -34.1%
Liabilities and Equity 67.5M USD -31.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.99M USD +32.8%
Net Cash Provided by (Used in) Financing Activities -200K USD +61.4%
Net Cash Provided by (Used in) Investing Activities 4.55M USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 52.4M shares +3.79%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.64M USD +67.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 40.3M USD -33.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD -97.8%
Deferred Tax Assets, Valuation Allowance 29.7M USD +11.2%
Deferred Tax Assets, Gross 31.1M USD +3.8%
Operating Lease, Liability 2.92M USD -20%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.1M USD -166%
Lessee, Operating Lease, Liability, to be Paid 3.18M USD -21.2%
Property, Plant and Equipment, Gross 27.1M USD -4.26%
Operating Lease, Liability, Current 817K USD -5.22%
Lessee, Operating Lease, Liability, to be Paid, Year Two 907K USD +2.37%
Lessee, Operating Lease, Liability, to be Paid, Year One 906K USD +1.12%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 265K USD -32.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 833K USD -5.45%
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 44K USD -94.6%
Additional Paid in Capital 343M USD -0.89%
Depreciation, Depletion and Amortization 319K USD +18.1%
Deferred Tax Assets, Net of Valuation Allowance 29.7M USD +11.2%
Share-based Payment Arrangement, Expense 181K USD -30.7%
Interest Expense -1.38M USD -2117%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%